Cytokinetics, Incorporated
CYTK
$77.22
$2.413.22%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -12.75% | -18.01% | -4.86% | -18.80% | 51.58% |
| Total Receivables | 239.31% | 6.69% | 640.98% | -- | 141.25% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -11.94% | 11.22% | 95.14% | 81.21% | -16.32% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | -12.19% | -17.24% | -4.05% | -16.98% | 49.69% |
|
|
|||||
| Total Current Assets | -12.19% | -17.24% | -4.05% | -16.98% | 49.69% |
| Net Property, Plant & Equipment | 8.55% | 10.07% | 9.26% | 2.38% | -1.08% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 75.72% | 125.06% | 117.61% | 89.52% | 62.49% |
| Total Assets | 0.75% | 1.63% | 0.03% | -19.57% | 56.43% |
|
|
|||||
| Total Accounts Payable | 77.23% | 9.66% | 90.69% | 71.36% | 7.52% |
| Total Accrued Expenses | 58.82% | 50.53% | 23.70% | 31.40% | 8.06% |
| Short-term Debt | 152.99% | 175.22% | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 102.15% | 97.69% | 24.86% | 13.18% | 9.36% |
| Total Finance Division Other Current Liabilities | -82.39% | -91.24% | -80.03% | -53.40% | 867.45% |
| Total Other Current Liabilities | -82.39% | -91.24% | -80.03% | -53.40% | 867.45% |
| Total Current Liabilities | 24.70% | 12.68% | 29.44% | 27.52% | 79.76% |
|
|
|||||
| Total Current Liabilities | 24.70% | 12.68% | 29.44% | 27.52% | 79.76% |
| Long-Term Debt | 62.58% | 61.27% | 55.26% | 31.60% | 26.04% |
| Short-term Debt | 152.99% | 175.22% | -- | -- | -- |
| Capital Leases | -7.16% | -4.10% | -3.57% | -4.87% | -4.39% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 12.13% | 12.19% | 12.50% | -8.47% | 26.29% |
| Total Liabilities | 37.22% | 35.60% | 35.02% | 12.66% | 27.09% |
|
|
|||||
| Common Stock & APIC | 10.50% | 10.24% | 9.88% | 5.13% | 40.11% |
| Retained Earnings | -28.98% | -29.05% | -29.47% | -25.36% | -27.37% |
| Treasury Stock & Other | -204.34% | -73.73% | -99.37% | 84.54% | 386.64% |
| Total Common Equity | -210.26% | -387.27% | -3,646.12% | -439.68% | 32.75% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -210.26% | -387.27% | -3,646.12% | -439.68% | 32.75% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -210.26% | -387.27% | -3,646.12% | -439.68% | 32.75% |
|
|
|||||